Clinician's Roundtable

Host: Charles Turck, PharmD, BCPS, BCCCP Emerging data over the years has shown the role of GLP-1 receptor agonists, not only in terms of their initial role in managing diabetes and blood sugar but also the secondary benefit of sometimes massive amounts of weight loss. However, there hasn’t been a tremendous number of studies looking at the use of these agents in patients with HIV. Join Dr. Charles Turck as he dives into the data further with Dr. Darcy Wooten, Clinical Professor of Medicine and a Program Director for the University of California San Diego ID Fellowship Training Program in the Division of Infectious Diseases and Global Public Health.

Host: Andrew Wilner, MD, FACP, FAAN Guest: Neil Skolnik, MD The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recently updated some of the recommendations for treating patients with chronic obstructive pulmonary disease (COPD). Two large conceptual changes occurred in this update: one is an increased emphasis on treating exacerbations, and the other is looking at decreasing mortality as an important treatment goal. Learn more about this and other key updates from the GOLD recommendations with Dr. Andrew Wilner and Dr. Neil Skolnik, Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University in Philadelphia.

Host: Jennifer Shu, MD, FAAP Guest: Steven H. Abman, MD Bronchopulmonary dysplasia is a chronic lung disease that can have significant impacts on a newborn’s overall respiratory health, making it imperative to know how to recognize and treat it. Tune in to hear Dr. Jennifer Shu talk about the symptoms, impacts, and treatment of bronchopulmonary dysplasia with Dr. Steven Abman, a Professor in the Department of Pediatrics at the University of Colorado School of Medicine and the Director of the Pediatric Heart Lung Center at Children’s Hospital Colorado.

Host: Dalmacio Dennis Flores, PhD, ACRN, FAAN According to a Gallup poll, Generation Z youth identify as LGBTQ more than previous generations. Given this increasing prevalence, clinicians need to know how to foster synergistic relationships between parents and LGBTQ+ youth. Here to discuss this important topic is Dr. Dalmacio Dennis Flores, an Assistant Professor at the University of Pennsylvania School of Nursing. He also spoke about this exact topic at the 2023 Annual ANAC conference in his session, titled “Synergy in Inclusive Sexual Health: Triadic Models Empowering LGBTQ+ Youth, Parents, and Nurses.”

Host: Jeffrey Kwong, DNP, MPH Managing co-occurring conditions in patients with HIV can be challenging. But by taking certain steps—like updating management guidelines, screening for complications, and implementing prevention strategies—we can overcome those challenges and improve the way we care for HIV patients with co-occurring conditions. Here to discuss those strategies is Dr. Jeffrey Kwong, a Professor in the Division of Advanced Nursing Practice at Rutgers University School of Nursing. He also spoke about this exact topic at the 2023 Annual ANAC conference in his session, titled “Managing Co-Occurring Conditions: A Clinical Update.”

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: William R. Short, MD, MPH, AAHIVS As of January 2023, the breastfeeding guidelines for HIV patients were updated, and they now recommend supporting the parent’s choice through shared decision-making. Joining Dr. Charles Turck to share what these new guidelines look like in practice and key counseling strategies for HIV patients is Dr. William Short. Dr. Short is an Associate Professor of Medicine and Infectious Disease at the University of Pennsylvania in Philadelphia, and he also spoke about this exact topic at the 2023 ANAC conference in his session, titled “New Recommendations for Infant Feeding for Persons with HIV in the United States.”

Host: Rachel Denyer, MD About one in every three people living with HIV has a positive hepatitis B core antibody. But how frequently does hepatitis B reactivation occur after a patient with HIV switches to an antiretroviral regimen that has no hepatitis B activity? Find out with Dr. Rachel Denyer as she shares key data she presented at IDWeek 2023 in the session titled “Hepatitis B Reactivation in Persons with HIV with Positive Hepatitis B Core Antibody After Switching to Antiretroviral Therapy Without Hepatitis B Activity.”

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Stuart M. Levitz, MD Treating fungal infections can be difficult due to the limited treatment options available, but could antifungal vaccines help change that? To catch us up on the progress being made in immunotherapeutic and vaccine strategies, Dr. Charles Turck speaks with Dr. Stuart Levitz about the “Antifungal Vaccines: Where Are We At?” session he presented at IDWeek 2023.

Host: Jeffrey Freiberg, MD, PhD The field of infectious diseases is always evolving thanks to new research studies, data, and treatment options. To help us catch up on some of these essential updates, Dr. Jeffrey Freiberg is here to give us an overview of the “What's Hot in ID in Clinical Science” session he helped develop for IDWeek 2023.

Host: Jay Fishman, MD With a global shortage of human organs, xenotransplantation offers a potential new way to save lives. But what are the immunologic barriers? Tune in as Dr. Jay Fishman, Director of Transplant Infectious Diseases and Compromised Host Program at Massachusetts General Hospital, recaps his session from the 2023 IDWeek.